Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
Systemic antibiotics and antibacterials
Cephalosporins and other beta-lactam antibiotics
XM3FN8Third-generation cephalosporins

XM85Q0 category

Cefpodoxime

Also indexed as

Cefpodoxime

Nearby in Third-generation cephalosporins

XM7CZ4Cefotaxime
XM94G4Ceftazidime
XM9732Cefsulodin
XM3P83Ceftriaxone
XM6FL0Cefmenoxime
XM0B94Latamoxef
XM1064Ceftizoxime
XM4Q77Cefixime

PreviousXM12J5 — Cefodizime NextXM2D98 — Ceftibuten

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
XM0QJ8Neuroprotective agents, not elsewhere classified
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
14 more
Systemic antibiotics and antibacterials
Antimycobacterials
Antifungal agents
Antiviral drugs
Antivenin, antivenom (sera), Immunoglobulin
Vaccines
Other specified systemic anti-infectives and antiparasitics
Antiprotozoal drugs
Anthelminthics
XM0MG9Amphenicols
Penicillins
XM9XT2Beta-lactamase inhibitors
Cephalosporins and other beta-lactam antibiotics
XM8SY8Sulfonamides and trimethoprim derivatives
Macrolides
XM7E36Lincosamides
XM69N7Streptogramins
Aminoglycosides
7 more
XM67G9Cephalothin
XM2K88Clavulanic acid
XM9BE0First-generation cephalosporins
XM4DG8Second-generation cephalosporins
XM3FN8Third-generation cephalosporins
XM60V7Fourth-generation cephalosporins
XM3XC6Monobactams
XM1JU9Carbapenems
XM3QS2Ceftobiprole medocaril
10 more
XM0B94Latamoxef
XM1064Ceftizoxime
XM4Q77Cefixime
XM8YC6Cefetamet
XM9YD6Cefpiramide
XM5425Cefoperazone
XM12J5Cefodizime
XM85Q0Cefpodoxime
XM2D98Ceftibuten
XM2141Cefdinir
XM2SP6Cefditoren
XM0H82Cefcapene
XM9RH3Cefotaxime and beta-lactamase inhibitor
XM8EN5Ceftazidime and beta-lactamase inhibitor
XM4UZ8Cefoperazone and beta-lactamase inhibitor
6 more

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact